Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
PAVULON (pancuronium bromide) is a neuromuscular blocking agent administered via injection used to facilitate intubation and provide skeletal muscle relaxation during anesthesia and mechanical ventilation. It works by competitively binding to acetylcholine receptors at the neuromuscular junction, preventing muscle contraction. This steroid-based agent is a mainstay in operating rooms and intensive care units for procedural sedation.
As a mature injectable anesthetic adjunct with approaching loss of exclusivity, the brand team is likely consolidating around maintenance and cost-management strategies rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on PAVULON offers limited career growth in innovation or brand expansion; opportunities are concentrated in institutional sales, cost-containment, and supply-chain roles where you manage market presence in competitive generic environments. This is a defensive, maintenance-oriented position best suited for professionals seeking stability in established markets rather than launch excitement or clinical development.
Worked on PAVULON at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.